117 related articles for article (PubMed ID: 19485908)
1. The impact of pharmacotherapy on the cardiopulmonary exercise test response in patients with heart failure: a mini review.
Guazzi M; Arena R
Curr Vasc Pharmacol; 2009 Oct; 7(4):557-69. PubMed ID: 19485908
[TBL] [Abstract][Full Text] [Related]
2. Cardiopulmonary exercise testing characteristics in heart failure patients with and without concomitant chronic obstructive pulmonary disease.
Guazzi M; Myers J; Vicenzi M; Bensimhon D; Chase P; Pinkstaff S; Arena R
Am Heart J; 2010 Nov; 160(5):900-5. PubMed ID: 21095278
[TBL] [Abstract][Full Text] [Related]
3. Optimizing the clinical application of cardiopulmonary exercise testing in patients with heart failure.
Guazzi M; Myers J; Arena R
Int J Cardiol; 2009 Sep; 137(1):e18-22. PubMed ID: 18684537
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of ventilatory efficiency with beta-blocker therapy in heart failure.
Arena RA; Guazzi M; Myers J; Abella J
Med Sci Sports Exerc; 2007 Feb; 39(2):213-9. PubMed ID: 17277583
[TBL] [Abstract][Full Text] [Related]
5. Cardiopulmonary exercise testing is a core assessment for patients with heart failure.
Arena R; Myers J; Guazzi M
Congest Heart Fail; 2011; 17(3):115-9. PubMed ID: 21609384
[TBL] [Abstract][Full Text] [Related]
6. The clinical and research applications of aerobic capacity and ventilatory efficiency in heart failure: an evidence-based review.
Arena R; Myers J; Guazzi M
Heart Fail Rev; 2008 Jun; 13(2):245-69. PubMed ID: 17987381
[TBL] [Abstract][Full Text] [Related]
7. Systolic blood pressure influences the interpretation of cardiopulmonary exercise tests and helps identify a very high-risk cohort of heart failure patients.
Bard RL; Gillespie BW; Lange DC; Pinter A; Nicklas JM
J Heart Lung Transplant; 2014 Apr; 33(4):388-96. PubMed ID: 24661454
[TBL] [Abstract][Full Text] [Related]
8. Greater prognostic value of peak VO2 after exercise training program completion in heart failure patients.
Tabet JY; Meurin P; Benzidi Y; Beauvais F; Ben Driss A; Weber H; Renaud N; Dumaine R; Grosdemouge A; Cohen Solal A
Int J Cardiol; 2013 Oct; 168(4):4139-44. PubMed ID: 23911267
[TBL] [Abstract][Full Text] [Related]
9. A cutoff point for peak oxygen consumption in the prognosis of heart failure patients with β-blocker therapy.
Guimaraes GV; d'Avila VM; Silva MS; Ferreira SA; Ciolac EG; Carvalho VO; Bocchi EA
Int J Cardiol; 2010 Nov; 145(1):75-7. PubMed ID: 19477026
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of the cardiopulmonary exercise test in patients with heart failure who have been treated with beta-blockers.
Dufay-Bougon C; Belin A; Dahdouh ZS; Barthelemy S; Mabire JP; Sabatier R; Milliez P; Grollier G
Turk Kardiyol Dern Ars; 2013 Mar; 41(2):105-12. PubMed ID: 23666296
[TBL] [Abstract][Full Text] [Related]
11. Cardiopulmonary Exercise Testing in Aortic Stenosis.
Le VDT
Dan Med J; 2017 May; 64(5):. PubMed ID: 28552098
[TBL] [Abstract][Full Text] [Related]
12. Cardiopulmonary exercise testing variables reflect the degree of diastolic dysfunction in patients with heart failure-normal ejection fraction.
Guazzi M; Myers J; Peberdy MA; Bensimhon D; Chase P; Arena R
J Cardiopulm Rehabil Prev; 2010; 30(3):165-72. PubMed ID: 20216325
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of cardiopulmonary exercise testing in heart failure with preserved ejection fraction. The Henry Ford HospITal CardioPulmonary EXercise Testing (FIT-CPX) project.
Shafiq A; Brawner CA; Aldred HA; Lewis B; Williams CT; Tita C; Schairer JR; Ehrman JK; Velez M; Selektor Y; Lanfear DE; Keteyian SJ
Am Heart J; 2016 Apr; 174():167-72. PubMed ID: 26995385
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic management of heart failure: neurohormonal agents.
Moser DK
Crit Care Nurs Clin North Am; 1993 Dec; 5(4):599-608. PubMed ID: 7905275
[TBL] [Abstract][Full Text] [Related]
15. Heart rate recovery after the 6 min walk test rather than distance ambulated is a powerful prognostic indicator in heart failure with reduced and preserved ejection fraction: a comparison with cardiopulmonary exercise testing.
Cahalin LP; Arena R; Labate V; Bandera F; Lavie CJ; Guazzi M
Eur J Heart Fail; 2013 May; 15(5):519-27. PubMed ID: 23397578
[TBL] [Abstract][Full Text] [Related]
16. Targeting of high peak respiratory exchange ratio is safe and enhances the prognostic power of peak oxygen uptake for heart failure patients.
Nakanishi M; Takaki H; Kumasaka R; Arakawa T; Noguchi T; Sugimachi M; Goto Y
Circ J; 2014; 78(9):2268-75. PubMed ID: 25056425
[TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase 5 inhibition with sildenafil reverses exercise oscillatory breathing in chronic heart failure: a long-term cardiopulmonary exercise testing placebo-controlled study.
Guazzi M; Vicenzi M; Arena R
Eur J Heart Fail; 2012 Jan; 14(1):82-90. PubMed ID: 22067410
[TBL] [Abstract][Full Text] [Related]
18. Heart rate response to graded exercise correlates with aerobic and ventilatory capacity in patients with heart failure.
Vallebona A; Gigli G; Orlandi S; Reggiardo G
Clin Cardiol; 2005 Jan; 28(1):25-9. PubMed ID: 15704528
[TBL] [Abstract][Full Text] [Related]
19. Cardiopulmonary Exercise Testing in Heart Failure.
Myers J; Arena R; Cahalin LP; Labate V; Guazzi M
Curr Probl Cardiol; 2015 Aug; 40(8):322-72. PubMed ID: 26096801
[TBL] [Abstract][Full Text] [Related]
20. Reproducibility of peak oxygen uptake and other cardiopulmonary exercise parameters: implications for clinical trials and clinical practice.
Keteyian SJ; Brawner CA; Ehrman JK; Ivanhoe R; Boehmer JP; Abraham WT;
Chest; 2010 Oct; 138(4):950-5. PubMed ID: 20522572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
